Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Specified Drug-Use Survey of Trelagliptin Tablets "Survey on long-term use in patients with type 2 diabetes mellitus"

Trial Profile

Specified Drug-Use Survey of Trelagliptin Tablets "Survey on long-term use in patients with type 2 diabetes mellitus"

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Nov 2018

At a glance

  • Drugs Trelagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Takeda Pharma
  • Most Recent Events

    • 23 Jul 2018 Planned End Date changed from 30 Apr 2021 to 31 Oct 2021.
    • 23 Jul 2018 Planned primary completion date changed from 30 Apr 2021 to 31 Oct 2021.
    • 04 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top